hero image
Rory E. Kim, PharmD, MACM, BCACP - USC School of Pharmacy. Los Angeles, CA, US

Rory E. Kim, PharmD, MACM, BCACP Rory E. Kim, PharmD, MACM, BCACP

Assistant Professor of Clinical Pharmacy | USC School of Pharmacy


Rory Kim is an expert in clinical pharmacy, ambulatory care, and academia.

Social Media


Rory O'Callaghan Kim is an Assistant Professor of Clinical Pharmacy at the University of Southern California School of Pharmacy. After receiving her Doctorate in Pharmacy from the University of Kansas in May 2008, Dr. Kim moved to Los Angeles to pursue her post-doctoral training at USC. She completed a PGY1 Pharmacy Residency in Ambulatory Care in 2009 and a Fellowship in Ambulatory Care and Academia in 2010.

After completion of her post-doctoral training, she accepted a position with USC as a clinical pharmacist implementing comprehensive medication management programs into safety net clinics in Los Angeles. She was hired as a faculty member at USC in July 2013. She is currently the residency program director for the PGY1 Ambulatory Care residency. She is the course co-coordinator for the Pharmacy Literature Analysis & Drug Information course as well as the Health Care Needs for Special Populations Elective. She is the Chair of the PharmD Scholarly Project Committee. Dr. Kim received a Master of Academic Medicine from the Keck School of Medicine in 2018.

Areas of Expertise (10)


Interprofessional Education

Medication Adherence

Innovative Teaching Methodologies

Ambulatory Care

Clinical Pharmacy

Ambulatory Care and Academia

Comprehensive Medication Management



Education (2)

University of Kansas: Pharm.D.

University of Southern California: M.A.C.M.

Selected Articles (1)

Evaluation of provider response to positive depression screenings and physician attitudes on integrating psychiatric pharmacist services in primary care settings

Mental Health Clinician

Rory Kim et al.

2018 This was a retrospective chart review of patients ≥18 years of age seen in primary care clinics in Los Angeles County with a documented annual health screening (AHS) between January 1, 2015, through December 31, 2015. Primary outcomes were number and percentage of patients screened for depression with patient health questionnaire (PHQ) assessments, positive depression screenings, and interventions made for positive depression screenings. Secondary outcomes were PCPs' perceptions on management of depression, use of AHS, and roles for psychiatric pharmacists through evaluation of provider survey.

view more